Sionna Therapeutics Inc.
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Sionna Therapeutics Inc.
RECRUITINGPhase 1NCT07035990
Safety, Tolerability, and Pharmacokinetics of Multiple Dose Combinations of SION-451 and Complementary Modulators...
The purpose of Parts D and E of this Phase 1 study are to evaluate the safety, tolerability, and pharmacokinetics of multiple dose combinations of SION-451 and complementary...
Sponsor: Sionna Therapeutics Inc.Enrolling: 1442 locations
Cystic Fibrosis (CF)
RECRUITINGPhase 2NCT07108153
Proof-of-concept Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of SION-719 When...
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of SION-719 when given to people with CF who are already taking Trikafta.
Sponsor: Sionna Therapeutics Inc.Enrolling: 1613 locations
Cystic Fibrosis (CF)